Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Revance Therapeutics Inc. (RVNC)

11.86   -0.04 (-0.34%) 05-20 16:00
Open: 11.88 Pre. Close: 11.9
High: 11.98 Low: 11.65
Volume: 343,754 Market Cap: 522M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 11.998 - 12.082 12.082 - 12.146
Low: 11.431 - 11.545 11.545 - 11.632
Close: 11.702 - 11.857 11.857 - 11.975

Technical analysis

as of: 2019-05-20 4:30:05 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 14.98     One year: 16.65
Support: Support1: 10.51    Support2: 8.74
Resistance: Resistance1: 12.82    Resistance2: 14.25
Pivot: 12.77
Moving Average: MA(5): 12.29     MA(20): 12.91
MA(100): 16.11     MA(250): 21.88
MACD: MACD(12,26): -0.61     Signal(9): -0.58
Stochastic oscillator: %K(14,3): 46.23     %D(3): 54.76
RSI: RSI(14): 29.08
52-week: High: 32.45  Low: 10.51  Change(%): -60.9
Average Vol(K): 3-Month: 38434  10-Days: 46086

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
RVNC has closed above bottom band by 6.3%. Bollinger Bands are 12.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 09 May 2019 16:01:56 Z
Revance Therapeutics (RVNC) Q1 2019 Earnings Call Transcript

Wed, 01 May 2019 17:22:19 Z
Will Revance Therapeutics (RVNC) Report Negative Earnings Next Week? What You Should Know

Wed, 24 Apr 2019 22:10:38 Z
10 Monster Growth Stocks to Buy for 2019 and Beyond

Wed, 27 Feb 2019 02:07:42 Z
Revance Therapeutics Inc (RVNC) Q4 2018 Earnings Conference Call Transcript

Thu, 07 Feb 2019 00:06:42 Z
10 Monster Growth Stocks to Buy for 2019 and Beyond

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 44.01
Shares Float (M) 43.39
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -3.940
EPS Est. Current Year -3.610
EPS Est. Next Year -3.410
EPS Est. Next Quarter -0.940
Forward EPS -3.942
Book Value (p.s.) 2.440
PEG Ratio -0.30
Profit Margin
Operating Margin -3765.05
Return on Assets (ttm) -48.9
Return on Equity (ttm) -65.4
Qtrly Rev. Growth 44.0
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -104.52
Levered Free Cash Flow (M) -71.09

Stock Valuations

P/E -3.01
P/E Growth Ratio
P/BV 4.86
P/S 5219586048.00
P/CF -4.99

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.